SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001072613-21-000297
Filing Date
2021-03-11
Accepted
2021-03-10 21:40:22
Documents
1
Group Members
FOREST BASKETTGROWTH EQUITY OPPORTUNITIES FUND, LLCKRISHNA S. KOLLURIMICHAEL JAMES BARRETTNEA 12 GP, LLCNEA PARTNERS 12, LIMITED PARTNERSHIPPATRICK J. KERINSPETER J. BARRISSCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 NEW ENTERPRISE ASSOCIATES 12, LP (VIRACTA) - SCHEDULE 13DA5E nea12-viracta_18475.htm SC 13D/A 102886
  Complete submission text file 0001072613-21-000297.txt   104937
Mailing Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007
Business Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007 858-400-8470
Viracta Therapeutics, Inc. (Subject) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81034 | Film No.: 21731651
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 1119 ST. PAUL STREET BALTIMORE MD 21202
Business Address 1119 ST. PAUL STREET BALTIMORE MD 21202 4102440115
New Enterprise Associates 12, Limited Partnership (Filed by) CIK: 0001383391 (see all company filings)

IRS No.: 204670653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A